Multiply Labs is doing for cell remedy labs what has already occurred within the chip business: It’s introducing robots to do the tedious, precision and hygienic work higher, sooner and cheaper.
The startup idea was sparked when Fred Parietti was at MIT doing PhD analysis in robotics and he met with Alice Melocchi, who confirmed him how these laborious labs lacked automation whereas risking contamination.
“She confirmed me what she did in a lab and the way troublesome it was, and I couldn’t consider it — I believed medicine had been made like chips, and this was insane but additionally actual,” mentioned Parietti, co-founder and CEO of Multiply Labs. “Subsequent, I flew to Silicon Valley, and we began this at YCombinator.”
San Francisco-based Multiply Labs, based in 2016, at present is automating cell remedy manufacturing with robots for main corporations, together with Kyverna Therapeutics and Legend Biotech.
Multiply Labs provides end-to-end robotic techniques that produce gene modified cell therapies at scale.
Much like how the semiconductor business has developed from clear rooms with technicians in bunny fits, A number of Labs is ushering on this new period for biosciences. Like with chips at present, it guarantees precision positive factors, decreased contamination and superior manufacturing with bodily AI.
Multiply Labs techniques are bringing these therapeutics into the long run utilizing NVIDIA Omniverse libraries for creating digital twins of those lab environments and the NVIDIA Isaac Sim robotics simulation framework for coaching robots on the bespoke abilities required to develop these therapies. It’s additionally creating humanoid robots utilizing the NVIDIA Isaac GR00T humanoid basis robotic mannequin for helping within the labs with improved hygiene.
Cell therapies are new and contain taking cells from a affected person or donor and modifying them for treating sufferers to battle illnesses or a affected person’s personal immune response. They present promise for treating cancers, genetic problems, autoimmune illnesses and neurological situations.
These artisanal therapies — one-offs for particular sufferers — are costly to provide and may simply be destroyed within the course of by contamination or improper dealing with. Robots inside the managed biomanufacturing clusters of Multiply Labs assist guarantee extra hygienic and precision processes.
“It must be sterile, and also you don’t need anybody respiratory anyplace close to the cells, so it was an apparent excessive worth software of robotics,” mentioned Parietti.
Simulating Cell Remedy Manufacturing Abilities for Improved Precision in Labs
Cell remedy manufacturing is advanced, expensive, and liable to failure. Bioscience corporations are turning to automation and simulation to cut back threat, scale output and protect skilled information. A key growth is imitation studying — coaching robots in Isaac Sim to copy skilled duties by analyzing video demonstrations. This strategy captures the tacit, usually undocumented abilities of high scientists and interprets them into robotic management insurance policies.
